Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent
1991-01-14
1993-03-09
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
514192, 514200, 514398, 514503, A61K 3165, A61K 3143, A61K 31545, A61K 31415, A61K 3129
Patent
active
051927527
ABSTRACT:
Oral pharmaceutical compositions in unit dosage form suitable for swallowing (especially capsules) comprising a safe and effective amount of solid Colloidal Bismuth Subcitrate (CBS), and optionally one or more pharmaceutically-acceptable carrier materials, wherein the packing density of the dosage unit is less than about 1 g/ml.
REFERENCES:
patent: 4801454 (1989-01-01), Conveney
patent: 4801608 (1989-01-01), Bos et al.
patent: 4940695 (1990-07-01), Conveney et al.
patent: 5008256 (1991-04-01), Clitherow
patent: 5013560 (1991-05-01), Stentz et al.
Nwokolo et al. Aliment. Pharmacol. Therap., (1989), 3, pp. 21-28.
Chapura Francis B.
Mitra Sekhar
Henley III Raymond J.
Mohl Douglas C.
The Procter & Gamble & Company
Waddell Frederick E.
Witte Richard C.
LandOfFree
Swallowable pharmaceutical compositions containing Colloidal Bis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Swallowable pharmaceutical compositions containing Colloidal Bis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Swallowable pharmaceutical compositions containing Colloidal Bis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-211561